Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...
TipRanks on MSN
Sun Pharma’s New Clinical Trial: A Potential Game-Changer for Actinic Keratosis Treatment
Sun Pharmaceutical Industries Limited (($IN:SUNPHARMA)) announced an update on their ongoing clinical study. Sun Pharmaceutical Industries Limited ...
Torqur AG, subsidiary of Swiss Rockets incubator and a clinical-stage company advancing targeted therapies in oncodermatology and oncology, announced the results of the full Phase 2 proof-of-concept ...
Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more If you suffer from those persistent ...
Torqur AG Announced Full Phase 2 Results at EADV Congress 2025 BASEL, Switzerland, October 06, 2025--(BUSINESS WIRE)--Torqur AG, subsidiary of Swiss Rockets incubator and a clinical-stage company ...
Background: Differentiating Actinic keratosis (AK) from Seborrheic keratosis (SK) can be challenging for dermatologists due to their visual similarities. This multi-center prospective study aims to ...
Department of Dermatology, Dermatology Hospital of Zhejiang Province, Huzhou, Zhejiang, China Introduction: Scalp seborrheic dermatitis (SSD) is a common, chronic inflammatory skin disease. Its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results